Arvinas Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include NextCure and Stelexis Therapeutics.

	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.	Stelexis Therapeutics Stelexis Therapeutics is a cancer therapeutics company.
Founding Date	Founding Date 2018	Founding Date 2015	Founding Date 2017
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy	Tags Healthcare Technology drug development oncology pharma therapy
Locations	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Beltsville, US HQ	Locations New York, US HQ
Employees	Employees 188	Employees N/A	Employees 3
Valuation ($)	Valuation ($) 243.3 m	Valuation ($) 39.2 m	Valuation ($) N/A
Financial
Net income	Net income ($274.4m) (FY, 2025)	Net income ($55.8m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 160m	Total funding raised $ 43m

For sources of this data, please see the company profile

Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

New York, US

Employees

Stelexis Therapeutics is a cancer therapeutics company.

Financial